Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Results from the International, Multi-Center, Retrospective B-Holistic Study: Describing Treatment Pathways and Outcomes for Classical Hodgkin Lymphoma

Burhan Ferhanoglu, MD, Tae Min Kim, MD PhD, Amado Karduss, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Gayane Tumyan, Mubarak Al Mansour, Marta Zerga, MD, Yuqin Song, MD PhD, Silvia Rivas-Vera, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, Su-Peng Yeh, MD, Arif Abdillah, MD, Zhongwen Huang, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg, MBBS PhDFRACP FRCPA

Blood (2020) 136 (Supplement 1): 32–34.

https://doi.org/10.1182/blood-2020-134885

Published: 2020

Journal Articles

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Blood (2019) 134 (Supplement_1): 1613.

https://doi.org/10.1182/blood-2019-123841

Published: 2019

Journal Articles

Response to First-Line Treatment in Patients with N/K T-Cell Lymphoma. Experience of a Third Level Mexican Institute

Katheryn Betsabe Garzón, MD, Silvia Rivas-Vera, MD, Brenda L. Acosta-Maldonado, MD

Blood (2019) 134 (Supplement_1): 5286.

https://doi.org/10.1182/blood-2019-129887

Published: 2019

Journal Articles

18F-Fluorodeoxyglucose Positron Emission Tomography Versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients: Real-World Clinical Management of Patients at the National Cancer Institute, México

Tania Aguado, MD, Antonio Olivas-Martinez, MD, Uvi Cancino-Ramos, MD, Diego Zúñiga, MD, Carmen Lome, MD, Silvia Rivas-Vera, MD, Myrna Candelaria, MD PharmD

Blood (2019) 134 (Supplement_1): 5813.

https://doi.org/10.1182/blood-2019-126231

Published: 2019

Journal Articles

Role of Bone Marrow Infiltration and POD 24 in Follicular Lymphoma

Silvia Rivas-Vera, MD, Brenda Lizeth Acosta-Maldonado, MD, Lizeth Elisua Estrada-Martínez, MDcal student

Blood (2018) 132 (Supplement 1): 5336.

https://doi.org/10.1182/blood-2018-99-120066

Published: 2018

Journal Articles

International Prognostic Indexes (IPI, RIPI, NCCN-IPI) for Predicting Overall Survival in Diffuse Large B-Cell Lymphoma Can be Improved By Adding Serum Albumin As Another Predictive Factor. Retrospective Study of the Mexican Study Group in Lymphoma from a Database of 855 Patients

Luis Mario VILLELA Martinez, MD, Ana Ramirez-Ibarguen, MD, Efreen Montaño Figueroa, PhD, Montserrat Rojas-Sotelo, MD, Fernando Perez-Jacobo, MD, Gisela B. Gomez-Cruz, MD, Silvia Rivas-Vera, MD, Jorge Duque, MD, Sergio Tena, MD, Yocanxochitl Perfecto-Avalos, MS, Guillermo Ruiz Arguelles, MD, David Gomez-Almaguer, MD, Carlos Best, MD, Arianna Robles-Rodriguez, MD, Alicia Guzman

Blood (2018) 132 (Supplement 1): 1707.

https://doi.org/10.1182/blood-2018-99-118411

Published: 2018

Journal Articles

Interim Analysis Results from an International, Multi-Centre, Non-Interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients with Classical Hodgkin Lymphoma: B-CD30+ Hodgkin Lymphoma International Multi-Centre Retrospective Study of Treatment Practices and Outcomes (B-HOLISTIC)

Burhan Ferhanoglu, MD, Tae Min Kim, Gayane Tumyan, DMSc, MD PhD, Su-Peng Yeh, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Amado Karduss, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, FAMS, Mubarak Al Mansour, MD, Silvia Rivas-Vera, MD, Yuqin Song, MD PhD, Marta Zerga, MD, Julie Blair, PhD MD MPhil, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg

Blood (2018) 132 (Supplement 1): 2917.

https://doi.org/10.1182/blood-2018-99-111146

Published: 2018

Journal Articles

Clinical Presentation and Outcome of ABVD-Treated Elderly Versus Younger Patients with Classical Hodgkin´s Lymphoma

Brenda Lizeth Acosta-Maldonado, MD, Ana Ramirez-Ibarguen, MD, Flavio A Grimaldo-Gomez, MD, Silvia Rivas-Vera, MD

Blood (2014) 124 (21): 4404.

https://doi.org/10.1182/blood.V124.21.4404.4404

Published: 2014

Journal Articles

The Prognostic Significance of the Absolute Lymphocyte to Monocyte Count Ratio (ALC/AMC-dx) at Diagnosis in Hodgkin´s Lymphoma

Brenda Lizeth Acosta-Maldonado, MD, Ana Ramirez-Ibarguen, MD, Flavio A Grimaldo-Gomez, MD, Luis Oñate-Ocaña, MD, Silvia Rivas-Vera, MD

Blood (2014) 124 (21): 2953.

https://doi.org/10.1182/blood.V124.21.2953.2953

Published: 2014

Journal Articles

Central Nervous System Involvement in Primary Nasal Lymphoma.

Nora Sobrevilla-Moreno, MD, Marcela Janka-Zires, MD, Pedro Sobrevilla-Calvo, MD, Luis Durazo-Cons, MD, Silvia Rivas-Vera, MD

Blood (2009) 114 (22): 2940.

https://doi.org/10.1182/blood.V114.22.2940.2940

Published: 2009

Journal Articles

Extranodal NK/T-Cell Lymphoma, Nasal Type: Experience of Management in a Referral Hospital in a Development Country.

Humberto Castellanos-Sinco, MD, Silvia Rivas-Vera, MD, Victoria E. Ferrer Argote, MD, Christian Omar Ramos Peñafiel, MD, Ana Carmen Salinas-Torres, MD, Angélica Romo-Jiménez, MD, Merit Hernández-Sánchez, MD, Carlos Martínez-Murillo, MD

Blood (2009) 114 (22): 4767.

https://doi.org/10.1182/blood.V114.22.4767.4767

Published: 2009

Journal Articles

Non Hodgkin Lymphoma: Experience of a Referral Hospital.

Humberto Castellanos-Sinco, Silvia Rivas-Vera, MD, Victoria E. Ferrer Argote, MD, Carlos Martínez-Murillo, Christian Omar Ramos Peñafiel

Blood (2009) 114 (22): 4774.

https://doi.org/10.1182/blood.V114.22.4774.4774

Published: 2009

Journal Articles

T- Cell Non-Hodgkin's Lymphoma, Data From a Mexican Tertiary Health Center..

Silvia Rivas-Vera, MD, Mabel Oropeza-Borges, MD, Pedro Sobrevilla-Calvo, MD

Blood (2009) 114 (22): 5030.

https://doi.org/10.1182/blood.V114.22.5030.5030

Published: 2009

Journal Articles

Intrapleural Rituximab (R) Is Effective in Refractory Pleural Effusion Due to Non- Hodgkin’s Lymphoma

Silvia Rivas-Vera, MD, Carlos Cadena-Eumaña, MD, Juan Chalapud-Revelo, MD, Adriana Aguilar-Navarro, MD, Pedro Sobrevilla-Calvo, MD, Cristina Lievano-Torres

Blood (2008) 112 (11): 5004.

https://doi.org/10.1182/blood.V112.11.5004.5004

Published: 2008

Journal Articles

Fludarabine and Mitoxantrone for the Refractory Relapse Treatment of B-Cell Low-Grade Non-Hodgkin Lymphoma (NHL): LACOHG First Interim Report (Latin American Cooperative Oncology Hematology Group) .

Severiano Baltazar-Arellano, MD, Patricia Pimentel, MD, Luis Vera, MD, Fernando Bezares, MD, Jose Málaga, MD, Julia Huamani-Z, PharmD, Antonio Montante, MD, Silvia Rivas-Vera, MD, Antonio A. Carrasco-Yalan, MD, Brady E. Beltran-Garate, MD

Blood (2006) 108 (11): 4665.

https://doi.org/10.1182/blood.V108.11.4665.4665

Published: 2006

Journal Articles

High Incidence of Bcl-2/IgH Rearrangement in Mexican Patients With Follicular Lymphoma and Its Relevance as a Marker for Minimal Residual Disease.

Rosa M. Arana, QFB, Pedro Sobrevilla-Calvo, MD, Silvia Rivas-Vera, MD, Enrique Baez, MD, Severiano Baltazar, MD, Jorge Duque, MD, Ignacio Gregorio, MD, Francisco Tripp, MD, Oscar Garces, MD, Luis Aguilar, MD, Luis Flores, MD

Blood (2005) 106 (11): 4493.

https://doi.org/10.1182/blood.V106.11.4493.4493

Published: 2005

Journal Articles

Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin’s Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP.

Silvia Rivas-Vera, MD, Enrique Baez, MD, Pedro Sobrevilla-Calvo, MD, Severiano Baltazar, MD, Francisco Tripp, MD, Jorge Vela, MD, Oscar Garces, MD, Luis Aguilar, MD, Gregorio Ignacio, MD, Jorge Duque, MD, Petty Rodriguez, MD, Gustavo Reyes, MD

Blood (2005) 106 (11): 2431.

https://doi.org/10.1182/blood.V106.11.2431.2431

Published: 2005

Journal Articles

Marked Improvement in Detecting the Number of Involved Nodal Areas in Lymphoma, Using 18 F- FDG - PET and CT Scan.

Juan Chalapud, MD, Pedro Sobrevilla-Calvo, MD, Silvia Rivas-Vera, MD, Javier Altamirano-Levy, MD

Blood (2005) 106 (11): 1344.

https://doi.org/10.1182/blood.V106.11.1344.1344

Published: 2005

NARROW

Results from the International, Multi-Center, Retrospective B-Holistic Study: Describing Treatment Pathways and Outcomes for Classical Hodgkin Lymphoma

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Response to First-Line Treatment in Patients with N/K T-Cell Lymphoma. Experience of a Third Level Mexican Institute

18F-Fluorodeoxyglucose Positron Emission Tomography Versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients: Real-World Clinical Management of Patients at the National Cancer Institute, México

Role of Bone Marrow Infiltration and POD 24 in Follicular Lymphoma

International Prognostic Indexes (IPI, RIPI, NCCN-IPI) for Predicting Overall Survival in Diffuse Large B-Cell Lymphoma Can be Improved By Adding Serum Albumin As Another Predictive Factor. Retrospective Study of the Mexican Study Group in Lymphoma from a Database of 855 Patients

Clinical Presentation and Outcome of ABVD-Treated Elderly Versus Younger Patients with Classical Hodgkin´s Lymphoma

The Prognostic Significance of the Absolute Lymphocyte to Monocyte Count Ratio (ALC/AMC-dx) at Diagnosis in Hodgkin´s Lymphoma

Central Nervous System Involvement in Primary Nasal Lymphoma.

Extranodal NK/T-Cell Lymphoma, Nasal Type: Experience of Management in a Referral Hospital in a Development Country.

Non Hodgkin Lymphoma: Experience of a Referral Hospital.

T- Cell Non-Hodgkin's Lymphoma, Data From a Mexican Tertiary Health Center..

Intrapleural Rituximab (R) Is Effective in Refractory Pleural Effusion Due to Non- Hodgkin’s Lymphoma

Fludarabine and Mitoxantrone for the Refractory Relapse Treatment of B-Cell Low-Grade Non-Hodgkin Lymphoma (NHL): LACOHG First Interim Report (Latin American Cooperative Oncology Hematology Group) .

High Incidence of Bcl-2/IgH Rearrangement in Mexican Patients With Follicular Lymphoma and Its Relevance as a Marker for Minimal Residual Disease.

Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin’s Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP.

Marked Improvement in Detecting the Number of Involved Nodal Areas in Lymphoma, Using 18 F- FDG - PET and CT Scan.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only